Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
Swaminath A, Wierzbicki M, Parpia S, Wright JR, Tsakiridis TK, Okawara GS, Kundapur V, Bujold A, Ahmed N, Hirmiz K, Kurien E, Filion E, Gabos Z, Faria S, Louie AV, Owen T, Wai E, Ramchandar K, Chan EK, Julian J, Cline K, Whelan TJ. Swaminath A, et al. Among authors: ahmed n. Clin Lung Cancer. 2017 Mar;18(2):250-254. doi: 10.1016/j.cllc.2016.08.002. Epub 2016 Oct 3. Clin Lung Cancer. 2017. PMID: 27876603 Clinical Trial.
Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial.
Tsakiridis T, Pond GR, Wright J, Ellis PM, Ahmed N, Abdulkarim B, Roa W, Robinson A, Swaminath A, Okawara G, Wierzbicki M, Valdes M, Levine M. Tsakiridis T, et al. Among authors: ahmed n. JAMA Oncol. 2021 Sep 1;7(9):1333-1341. doi: 10.1001/jamaoncol.2021.2328. JAMA Oncol. 2021. PMID: 34323924 Free PMC article. Clinical Trial.
Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
Aduquaye M, Dube S, Bashir B, Chowdhury A, Ahmed N, Leylek A, Kim J, Lambert P, Bucher O, Hunter W, Sivananthan G, Koul R, Rathod S. Aduquaye M, et al. Among authors: ahmed n. Curr Oncol. 2022 Jan 4;29(1):193-208. doi: 10.3390/curroncol29010019. Curr Oncol. 2022. PMID: 35049693 Free PMC article.
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.
Swaminath A, Wierzbicki M, Parpia S, Kundapur V, Faria S, Ahmed N, Bujold A, Hirmiz K, Owen T, Leong N, Ramchandar K, Filion E, Lau H, Thompson R, Yaremko B, Gabos Z, Mehiri S, Wright JR, Tsakiridis TK, Cline K, Whelan TJ. Swaminath A, et al. Among authors: ahmed n. Clin Transl Radiat Oncol. 2022 Oct 13;37:145-152. doi: 10.1016/j.ctro.2022.10.002. eCollection 2022 Nov. Clin Transl Radiat Oncol. 2022. PMID: 36275452 Free PMC article.
Clinical Implementation of a Model-Based In Vivo Dose Verification System for Stereotactic Body Radiation Therapy-Volumetric Modulated Arc Therapy Treatments Using the Electronic Portal Imaging Device.
McCowan PM, Asuni G, Van Uytven E, VanBeek T, McCurdy BM, Loewen SK, Ahmed N, Bashir B, Butler JB, Chowdhury A, Dubey A, Leylek A, Nashed M. McCowan PM, et al. Among authors: ahmed n. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1077-1084. doi: 10.1016/j.ijrobp.2017.01.227. Epub 2017 Feb 2. Int J Radiat Oncol Biol Phys. 2017. PMID: 28332992 Clinical Trial.
3,881 results